Continue to Site

After a lackluster 2nd qtr, Hansen Medical gets a $93 million equity infusion

By Frank Tobe | July 31, 2013

Although the number of procedures using Hansen Medical‘s Magellan and Sensei robotic systems has risen, the number of units sold has fallen slightly and the company continues to operate in the red, hence the need for additional funding.

Hansen’s stock NASDAQ:HNSN, has traded in the $2 to $1.50 range for the last few years and lower this last month.

Oracle Investment Management, a med-tech investment management company headed by Larry N. Feinberg, did the deal and gains a seat on the Hansen board.

UPDATE 8/26/13: Hansen just made a long-term debt agreement with White Oak Global Advisors. The proceeds which will be used to retire the Company’s previous $30 million debt and fees due August 23rd. It is unclear whether this debt and debt repayment is part of the equity infusion from above.

About The Author

Frank Tobe

Frank Tobe is the founder of The Robot Report and co-founder of ROBO Global which has developed a tracking index for the robotics industry, the ROBO Global™ Robotics & Automation Index. The index of ~90 companies in 13 sub-sectors tracks and captures the entire economic value of this global opportunity in robotics, automation and enabling technologies.